News | News By Subject | News by Disease News By Date | Search News

Metastasis, cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Approves Bayer HealthCare (BAY), Onyx Pharmaceuticals, Inc. (ONXX)'s NEXAVAR® To Treat Type Of Thyroid Cancer     11/25/2013
Amgen (AMGN) Presents Interim Overall Survival Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma     11/19/2013
Amgen (AMGN)'s Xgeva Gains National Institute for Clinical Excellence (NICE) Recommendation for Bone Metastasis     8/17/2012
FDA Approves Sanofi (France) (SAN.PA)-Regeneron Pharmaceuticals, Inc. (REGN)'s Zaltrap for Metastatic Colorectal Cancer     8/6/2012
Idera Pharmaceuticals, Inc. (IDRA)'s IMO-2055 Disappoints in Phase 2 Study     5/3/2012
FDA Rejects Amgen (AMGN)'s Application for Xgeva     5/1/2012
Argos Therapeutics, Inc. Raises $25 Million Series D Financing     4/24/2012
Bayer AG (BAY.F) Gastrointestinal Cancer Drug Meets Phase 3 Trial Goal     4/4/2012
Active Biotech AB (BTPC)'s Prostate Cancer Project TASQ Featured in Journal of Clinical Oncology     9/20/2011
Synta Pharmaceuticals (JOBS) Suspends Elesclomol SYMMETRYSM Trial in Metastatic Melanoma     2/27/2009
Genentech, Inc. (DNA) Announces Resubmission of Supplemental Biologics License Application for Avastin in Combination with Paclitaxel for First-Line Metastatic Breast Cancer     8/24/2007
OSI Pharmaceuticals, Inc. (OSIP) Announces Tarceva Granted Approval In Canada For The Treatment Of Advanced Non-Small Cell Lung Cancer     7/14/2005
Berlex Inc. Release: Further Trial Data Awaited For Bonefos(R) (NDA) In The U.S.; Stocks Drop     5/11/2005

News from Around the Web
No Help from Continuous Tx in Metastatic RCC, Memorial Sloan-Kettering Cancer Center Study     2/22/2011
New Drug for Metastatic Melanoma Shows Promising Results in Clinical Trial, Vanderbilt University Medical Center Reveals     11/11/2010
ESMO: Obesity Does Not Interfere with Trastuzumab Response, Vall d'Hebron University Hospital Study     10/11/2010
Targeted Therapy Promising for HER2-Positive Metastatic Breast Cancer, Mayo Clinic Study     10/8/2010
Targeted Immunotherapy Shows Promise for Metastatic Breast, Pancreatic Cancers, University of Pennsylvania Study     6/2/2010
Researchers Identify Mechanism Used By Gene To Promote Metastasis In Human Cancer Cells, Virginia Commonwealth University And VCU Massey Cancer Center Study     9/30/2008
Androgen Production Continues in Prostate Cancer Tumors, Fred Hutchinson Cancer Research Center Study Finds     6/4/2008
New Cancer Stem Cell Driving Metastatic Tumors Identified In Cornell University's Weill Medical College Study     5/28/2008
First Targeted Therapy To Produce Remission Of Metastatic Melanoma, Dana-Farber Cancer Institute Research     4/21/2008
Report Describes First Targeted Therapy To Produce Remission Of Metastatic Melanoma, Dana-Farber Cancer Institute Study     4/18/2008
How Does Fu-Zheng-Jie-Du-Decoction Act On Pten Expression In Hepatocellular Carcinoma?     1/16/2008
Cold Spring Harbor Laboratory Scientists Identify Cells That Promote Formation of Lethal Lung Metastases     1/15/2008
Weizmann Institute of Science Scientists Discover a Control Mechanism for Metastasis     8/8/2007
University of Pittsburgh Scientists Find New Contributor to Aggressive Cancers     6/6/2007
Drug Used For Advanced Cancer Could Cause Exposed Bone In Jaw     10/3/2006

Press Releases
OncoSec Medical Inc. To Present At Scientific And Investment Conferences In September     9/2/2015
TrovaGene, Inc. And U.S. Oncology Research Collaborate On A Prospective Study For Urine-Based KRAS Testing In Patients With Metastatic Pancreatic Cancer     1/6/2014
BerGenBio AS Announces Initiation of Phase I Clinical Trial for First-in-Class AXL Receptor Tyrosine Kinase Inhibitor BGB324 to Treat Aggressive and Metastatic Cancers     6/20/2013
Successful Phase One Demonstrates Tumor Response With Increased Overall Survival for Lead VBL Therapeutics Compound in Cancer     5/16/2013
Marina Biotech, Inc. Announces That Licensee Mirna Therapeutics, Inc. Reported Initiation of a Phase 1 Clinical Trial of Anticancer Drug MRX34     5/13/2013
Max Planck Institute of Biochemistry, Lead Discovery Center and Qurient Close License Deal on a New Compound Against Metastatic and Drug-Resistant Cancers     3/12/2013
Oncomatrix Signs an Agreement With the University of Stuttgart to Develop New Drugs for Treating Tumor Metastases     12/10/2012
CytRx Corporation (CYTR) Advancing Aldoxorubicin (INNO-206) Development With Pharmacokinetic Study in Patients With Metastatic Solid Tumors     10/15/2012
PsiOxus Therapeutics Limited Launches Phase I/II Clinical Trial of Oncolytic Vaccine With Dosing of Patient With Metastatic Cancer     9/26/2012
NBC News Reports that Cannabidiol (CBD) "Turns Off" the Cancer Gene Involved in Metastasis Findings by Scientists at California Pacific Medical Center Gives Scientific Support for Cannabis Science Inc. Initiatives     9/21/2012
Nuvilex Release: Completed Pancreatic Cancer Phase 1-2 Trial Concluded the Encapsulated Cells Produced Chemotherapy That May Treat Downstream Micro Metastatic Disease     3/13/2012
Provectus Pharmaceuticals Inc. Receives Guidance From FDA on Pathway to Approval for Phase 3 Trial of PV-10 For Metastatic Melanoma     1/18/2012
Alchemia Recruits First Patient to Pivotal Phase III Clinical Trial of HA-Irinotecan in Metastatic Colorectal Cancer     1/4/2012
Bone-Strengthening Drug Gives Pain Relief in Prostate Cancer Bone Metastases, Mount Vernon Cancer Centre Study     9/26/2011
OncoGenex Pharmaceuticals Inc. Release: A Phase III Clinical Trial Testing Long-Term Pain Management in Men With Metastatic Castrate-Resistant Prostate Cancer is Open and Enrolling     9/22/2011